Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Rating of “Buy” from Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has received a consensus rating of “Buy” from the six research firms that are covering the company, Marketbeat.com reports. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $12.13.

Several analysts have recently issued reports on BIOX shares. Canaccord Genuity Group lowered their price objective on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Oppenheimer lowered their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, October 21st.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. lifted its position in shares of Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after purchasing an additional 29,693 shares in the last quarter. Stifel Financial Corp lifted its holdings in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after buying an additional 10,224 shares in the last quarter. Fourth Sail Capital LP boosted its position in Bioceres Crop Solutions by 61.6% in the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock valued at $24,957,000 after buying an additional 1,209,277 shares during the last quarter. Long Focus Capital Management LLC grew its stake in shares of Bioceres Crop Solutions by 19.9% during the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after acquiring an additional 46,647 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after acquiring an additional 5,341 shares during the last quarter. 17.68% of the stock is owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Stock Performance

Shares of BIOX opened at $6.89 on Tuesday. Bioceres Crop Solutions has a 1 year low of $5.71 and a 1 year high of $14.05. The company’s 50 day simple moving average is $6.58 and its 200 day simple moving average is $8.25. The company has a market capitalization of $432.08 million, a price-to-earnings ratio of 344.67 and a beta of 0.56. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The company had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. During the same period in the prior year, the company earned ($0.07) EPS. On average, sell-side analysts predict that Bioceres Crop Solutions will post 0.12 EPS for the current year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.